Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease

被引:36
作者
Li, Jia [1 ]
Gu, Chengzhi [1 ]
Zhu, Min [1 ]
Li, Dan [1 ]
Chen, Lan [1 ]
Zhu, Xiangyang [1 ]
机构
[1] Second Affiliated Hosp Nantong Univ, Dept Neurol, Nantong, Peoples R China
关键词
blood lipid; cystatin C; homocysteine; Parkinson's disease; NONMOTOR SYMPTOMS; TREMOR-DOMINANT; MOTOR SUBTYPES; PATHOPHYSIOLOGY; CHOLESTEROL; DECLINE; ONSET;
D O I
10.1111/psyg.12483
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aim The aim was too study the correlations between blood lipid, serum cystatin C (Cys C) and homocysteine (Hcy) levels in patients with Parkinson's disease (PD). Methods A total of 322 PD patients and 214 healthy subjects were selected as case and control groups, respectively. The risk factors were explored by logistic regression analysis. The case group was subtyped according to main motor symptoms and age of onset. The correlations of significantly different indices with age, duration of disease, and equivalent dose of levodopa were studied by Spearman's correlation analysis. Receiver operating characteristic curves were plotted to analyze diagnostic values. Results Compared to the control group, the PD group had lower serum total cholesterol, triglyceride, and apolipoprotein B (Apo B) levels and higher high-density lipoprotein cholesterol (HDL-C), Hcy, and Cys C levels (P < 0.05). Decreased Apo B level and increased HDL-C and Hcy levels were independent risk factors (P < 0.05). The Cys C level of early-onset patients was lower than of late-onset patients (P < 0.05). Hcy (r = 0.198, P < 0.05) and Cys C (r = 0.281, P < 0.05) levels were positively correlated with age. Triglyceride level was negatively correlated with age (r = -0.202, P < 0.05) and disease duration (r = -0.198, P < 0.05). Unified Parkinson's Disease Rating Scale III score was positively correlated with disease duration (r = 0.435, P < 0.05) and equivalent dose of levodopa (r = 0.423, P < 0.05). The areas under the curve for Apo B, HDL-C, and Hcy levels were 0.341, 0.588, and 0.643, respectively (P < 0.05). The combination of Apo B, HDL-C, and Hcy levels showed high diagnostic value, with a sensitivity of 76.4% and specificity of 69.5%. Conclusions Low serum levels of total cholesterol, triglyceride, and Apo B, and high levels of HDL-C, Hcy, and Cys C may be correlated with PD onset and progression. Decreased Apo B level and elevated HDL-C and Hcy levels are independent risk factors. Early-onset and late-onset PD may have different progression mechanisms.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 26 条
[1]   Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes [J].
Antonini, Angelo ;
Yegin, Ashley ;
Preda, Cornelia ;
Bergmann, Lars ;
Poewe, Werner .
PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) :231-235
[2]   Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study [J].
Arie, L. ;
Herman, Talia ;
Shema-Shiratzky, S. ;
Giladi, N. ;
Hausdorff, J. M. .
JOURNAL OF NEUROLOGY, 2017, 264 (10) :2149-2157
[3]  
Boll MC, 2011, CURR NEUROPHARMACOL, V9, P350, DOI 10.2174/157015911795596577
[4]  
Choudhary Rakesh K, 2004, J Foot Ankle Surg, V43, P312, DOI 10.1053/j.jfas.2004.07.003
[5]   Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk [J].
Costa-Mallen, Paola ;
Zabetian, Cyrus P. ;
Agarwal, Pinky ;
Hu, Shu-Ching ;
Yearout, Dora ;
Samii, Ali ;
Leverenz, James B. ;
Roberts, John W. ;
Checkoway, Harvey .
PARKINSONISM & RELATED DISORDERS, 2015, 21 (09) :1087-1092
[6]   Elevation of cystatin C in susceptible neurons in Alzheimer's disease [J].
Deng, A ;
Irizarry, MC ;
Nitsch, RM ;
Growdon, JH ;
Rebeck, GW .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03) :1061-1068
[7]   Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease [J].
Doria, Margaux ;
Maugest, Lucie ;
Moreau, Thibault ;
Lizard, Gerard ;
Vejux, Anne .
FREE RADICAL BIOLOGY AND MEDICINE, 2016, 101 :393-400
[8]   Serum Cholesterol and Nigrostriatal R2*Values in Parkinson's Disease [J].
Du, Guangwei ;
Lewis, Mechelle M. ;
Shaffer, Michele L. ;
Chen, Honglei ;
Yang, Qing X. ;
Mailman, Richard B. ;
Huang, Xuemei .
PLOS ONE, 2012, 7 (04)
[9]   Mendelian forms of Parkinson's disease [J].
Gasser, Thomas .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07) :587-596
[10]   Diagnostic criteria for Parkinson disease [J].
Gelb, DJ ;
Oliver, E ;
Gilman, S .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :33-39